ENTITY
Icure Pharm Inc

Icure Pharm Inc (175250 KS)

21
Analysis
Health CareSouth Korea
Icure Pharm. Inc. manufactures and distributes biopharmaceuticals. The Company produces drugs, cosmetics, and other biopharmaceuticals. Icure Pharm markets its products worldwide.
more
bullishIcure Pharm Inc
16 Feb 2021 04:38

KOSDAQ150 Index Rebalance Preview: Expected Inclusions Continue to Move Higher

We see 13 potential inclusions and exclusions at the June review of the KOSDAQ150 Index. After giving up some gains vs the expected deletes and the...

Logo
310 Views
Share
15 Dec 2020 06:32

KOSDAQ150 Index Rebalance Preview: Lots of Changes Expected Already; More to Come

Less than a third of the way through the review period, we see 14 potential inclusions and exclusions from the KOSDAQ150 index. The resumption of...

Logo
367 Views
Share
bearishIcure Pharm Inc
10 Jul 2018 08:45

Icure Pharm (175250 KS): Post IPO Short Selling Opportunity Checkup

Icure Pharm Inc (175250 KS) IPO price was set at ₩65,000. This is even higher than the upper end of the indicative price band, ₩44,000 - 55,000....

Logo
414 Views
Share
bullishIcure Pharm Inc
02 Jun 2018 11:48

Icure Pharm IPO Summary - Front Runner of Dementia Patch Development Race

Icure Pharm Inc (175250 KS) will offer a total of 1,200,000 shares (100% new rights offering) at ₩44,000 - ₩55,000 which gives a market cap of...

Logo
277 Views
Share
x